Results 151 to 160 of about 577,308 (213)

The Roles of Genetic and Epigenetic Abnormalities in Essential Thrombocythemia. [PDF]

Genes (Basel)
Strzała D, Homenda W, Połom A, Kellas A, Bilska S, Paszek S, Potocka-Wojtowicz N, Zawlik I.   +7 more
europepmc   +1 more source

Ophthalmological and epidemiological profiles of Brazilian patients with philadelphia-negative Myeloproliferative neoplasms. [PDF]

Hematol Transfus Cell Ther
Piloni-Parreira R, Barbosa MS, Neves LL, Santana HL, Rodrigues JMRDS, Tavares RS, Isaac DLC, Pereira de Ávila M.   +7 more
europepmc   +1 more source

Dengue Fever Unmasking JAK2 Mutation-Related Polycythemia Vera Presenting With Extensive Splanchnic Venous Thrombosis and Hemorrhagic Complications: A Diagnostic and Therapeutic Challenge. [PDF]

Cureus
Ayesha R, Sikandar F, Sikandar NUA, Tabasum A.   +3 more
europepmc   +1 more source

JAK2 V617F mutation, multiple hematologic and non-hematologic processes: an association? [PDF]

Biomark Res, 2016
Liu KG, Verma A, Derman O, Kornblum N, Janakiram M, Braunschweig I, Battini R.   +6 more
europepmc   +1 more source

JAK2-Positive Myeloproliferative Neoplasm: Polycythaemia Vera Presenting As Budd-Chiari Syndrome. [PDF]

Cureus
Malipatil R, Rao V R S, B S N, Ali Khan M.   +3 more
europepmc   +1 more source

Synchronous Coexistence of JAK2 V617F-Positive Essential Thrombocythemia and IgG Kappa Multiple Myeloma in an Octogenarian Patient: A Case Report. [PDF]

Case Rep Med
Ribero-Vargas M, Ahumada-Córdoba F, Silva-Pérez NM, Ribero-Vargas D.   +3 more
europepmc   +1 more source

Comparative Evaluation of Quantitative Real-Time PCR and a Laboratory-Developed Chip-Based Real-Time Digital PCR for <i>JAK2</i> V617F Allele Burden in Myeloproliferative Neoplasms. [PDF]

Diagnostics (Basel)
Park S, Kim K, Ha JS.
europepmc   +1 more source

Characterization of JAK2V617F and the JAK2 46/1 germline haplotype in myeloproliferative neoplasms in a Saudi Arabian cohort: a case-based analysis. [PDF]

Front Oncol
Mutrib N, Alqarni S, Peer-Zada AA, Samman M, Fatima S, Arjumand S, Aldahshan H, Alharbi KK, AlRashed MM.   +8 more
europepmc   +1 more source

MPL mutations are over-represented in patients with dual driver-mutated myeloproliferative neoplasms: an Irish cohort study. [PDF]

Hematol Transfus Cell Ther
Kearney L, Andrews C, Brodie R, Elhassadi E, Enright H, Fadalla K, Fay M, Flynn C, Fortune A, Hodgson A, Kumar S, Perera K, Sargent J, Smyth L, Langabeer SE.   +14 more
europepmc   +1 more source

Allele burden expansion in <i>JAK2</i> ^V617F and <i>CALR</i>-mutated myeloproliferative neoplasms predicts disease progression and is associated with anagrelide treatment. [PDF]

Hemasphere
Ng ZY, Cottin L, Demoy M, Luque Paz D, Orvain C, Lambert WC, Ianotto JC, Lippert E, Ross DM, Iarossi D, Khan A, Lock D, Truong C, Laribi K, Yang YF, Gagnon LL, Ugo V, Harrison CN, O'Sullivan J.   +18 more
europepmc   +1 more source